share_log

TherapeuticsMD Q3 EPS $(0.13) Misses $(0.05) Estimate

Benzinga ·  Nov 14, 2023 16:57

TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.05) by 160 percent. This is a 95.27 percent increase over losses of $(2.75) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment